Immediate and prolonged clinical efficacy of ceftazidime versus ceftazidime plus tobramycin in chronic pseudomonas aeruginosa infection in cystic fibrosis

Scandinavian Journal of Infectious Diseases

Volumn 18, Issue 2, 1986, Pages 133-137

  Pedersen, Svend Stenvang ^a   Pressler, Tanja ^a   Pedersen, Mogens ^a   Høiby, Niels ^a   Friis Møller, Alice ^a   Koch, Christian ^a  

^a Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CARBENICILLIN; CEFSULODIN; CEFTAZIDIME; TOBRAMYCIN;

CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CYSTIC FIBROSIS; DRUG COMPARISON; DRUG MIXTURE; DRUG SENSITIVITY; DRUG THERAPY; HUMAN; IN VITRO STUDY; INTRAVENOUS DRUG ADMINISTRATION; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY SYSTEM; RESPIRATORY TRACT INFECTION; THERAPY;

ADULT; CEFTAZIDIME; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; CLINICAL TRIALS; COMPARATIVE STUDY; CYSTIC FIBROSIS; DRUG THERAPY, COMBINATION; FEMALE; HUMAN; LUNG DISEASES; MALE; PSEUDOMONAS INFECTIONS; RANDOM ALLOCATION; TIME FACTORS; TOBRAMYCIN;

EID: 0022611090     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365548609032319     Document Type: Article

References (11)

1. Treatment of chronic Pseudomonas aeruginosa infection in cystic fibrosis patients with ceftazidime and tobramycin
2. Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of Pseudomonas aeruginosa precipitins determined by means of crossed immunoelectrophoresis. A survey
3. Antimicrobial chemotherapy in cystic fibrosis patients
4. Bakteriologiske undersøgelsemetoder
5. Antibiotic treatment of chronic Pseudomonas aeruginosa infection in cystic fibrosis patients
6. Treatment of pulmonary Pseudomonas aeruginosa infection in cystic fibrosis with cefsulodin
7. Ceftazidime treatment of chronic Pseudomonas aeruginosa respiratory tract infection in cystic fibrosis
8. Tables of critical values for the Pratt matched pair signed rank statistic
9. Emergence of resistance during therapy with the newer beta-lactam antibiotics; role of inducible beta-lactamases and implications for the future
10. Clinical results and pharmacokinetics of ceftazidime treatment in patients with cystic fibrosis
11. Frequent antibiotic therapy improves survival of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection